Transcatheter Aortic Valve‐in‐Valve Implantation for Failing Stentless Bioprosthetic Aortic Valves: An International Multicentre Retrospective Analysis

医学 外科 回顾性队列研究 经皮冠状动脉介入治疗 介入心脏病学 干预(咨询) 心导管术 假体设计 心脏病学 内科学 冠状动脉造影 梅德林 并发症
作者
Clare Rayner,Sarang Paleri,Satpal Singh Arri,Daijiro Tomii,Thomas Pilgrim,Pablo Codner,Ran Kornowski,Antonio Mangieri,Francesco Carlo Tartaglia,Victor Mauri,Ole De Backer,Yusuke Kobari,Luis Nombela-Franco y,Alfonso Ielasi,Mariama Akodad,Ruxandra Sava,Tiffany Patterson,Simon Robert Redwood,Heath S. L. Adams
出处
期刊:Catheterization and Cardiovascular Interventions [Wiley]
卷期号:107 (2): 647-654
标识
DOI:10.1002/ccd.70376
摘要

BACKGROUND: Valve-in-valve aortic valve implantation (ViV-TAVI) offers a less invasive treatment option for patients with a failing surgical bioprosthesis, avoiding the need for redo surgery. ViV-TAVI within a stentless bioprosthetic valve poses unique technical challenges. We report an international, multicentre experience evaluating procedural and clinical outcomes for patients undergoing ViV-TAVI for failed stentless bioprosthetic aortic valves. AIMS: To evaluate the procedural feasibility, safety, and clinical outcomes of ViV-TAVI performed for failed stentless bioprosthetic aortic valves in an international, multicentre cohort. METHODS: We retrospectively analysed 65 patients who underwent ViV-TAVI for stentless valve failure between 2010 and 2024. Outcome endpoints were based on the Valve Academic Research Consortium 3 (VARC-3) criteria. RESULTS: Sixty-five patients (mean age 78.8 ± 10.2 years; 66.1% male; mean STS-PROM 6.9 ± 4.7) were included. The mean interval between surgical valve implantation and failure was 12.9 ± 4.1 years, with regurgitation the predominant mechanism of valve dysfunction (52.3%). Procedural success was achieved in 92.3%. 17 patients (26.2%) had upfront coronary protection. Despite this, six patients required unplanned percutaneous coronary intervention (PCI) for coronary obstruction. The 30-day and 1-year mortality rate was 0% and 8% respectively. CONCLUSIONS: ViV-TAVI was an effective intervention for patients with failing stentless bioprosthetic valves, with high procedural success rates despite unique technical challenges. Careful preprocedural imaging, planning, and implementation of coronary protection strategies are critical for optimal patient outcomes.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
liquidwy发布了新的文献求助10
刚刚
轻飏发布了新的文献求助10
刚刚
肖123完成签到,获得积分10
刚刚
刚刚
刚刚
刚刚
WATCH完成签到,获得积分10
1秒前
1秒前
落尘发布了新的文献求助10
1秒前
keyantong完成签到,获得积分10
1秒前
666完成签到,获得积分10
1秒前
2秒前
2秒前
李爱国的应助被qqe采纳,获得10
2秒前
2秒前
月儿发布了新的文献求助10
3秒前
丰富的三问完成签到,获得积分10
3秒前
在水一方的应助被sunny采纳,获得10
3秒前
aajhajkahna的应助被聪慧冰淇淋采纳,获得10
3秒前
3秒前
无问西东发布了新的文献求助10
3秒前
3秒前
3秒前
大大大大宝凌完成签到,获得积分10
3秒前
今天也怪聪明的完成签到,获得积分10
4秒前
所所的应助被小阿志采纳,获得10
4秒前
养只缅因完成签到,获得积分10
4秒前
4秒前
4秒前
heady完成签到,获得积分10
4秒前
狂野迎海发布了新的文献求助10
4秒前
今后的应助被小巧的灵竹采纳,获得10
5秒前
5秒前
5秒前
高依民发布了新的文献求助10
5秒前
5秒前
hunbaekkkkk发布了新的文献求助10
6秒前
6秒前
6秒前
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8162755
求助须知:如何正确求助?哪些是违规求助? 9557016
关于积分的说明 21737907
捐赠科研通 7753093
什么是DOI,文献DOI怎么找? 3427901
关于科研通互助平台的介绍 2552719
邀请新用户注册赠送积分活动 2472528